Kanner, Andres M.
Shankar, Rohit
Margraf, Nils G.
Schmitz, Bettina
Ben-Menachem, Elinor
Sander, Josemir W.
Article History
Received: 26 September 2023
Accepted: 3 February 2024
First Online: 4 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: AMK has received honoraria from the Epilepsy Foundation of America as compensation for serving as Co-Editor in Chief of Epilepsy.com, honorarium for participating in advisory boards of: Neurelis, Angelini, honorarium for lectures on Psychiatric Aspects of Epilepsy: Jazz Pharmaceutical. RS has received institutional and research support from LivaNova, GW/Jazz pharma, UCB, Eisai, Veriton pharma, Averelle and Destin outside the submitted work. NGM reports personal fees from Eisai, Angelini and Jazz. Support for projects was granted by Jazz, Angelini, Eisai, UCB, LivaNova and Desitin. EBM Elinor received speakerĀ“s or consultancy fees from Angelini Pharma, Cogniguard, Theracule, Xenon and UCB-Pharma. BS has received speaker honoraria or consultancy fees from Angelini Pharma, Desitin, Eisai, Precisis, Sanofi, and UCB-Pharma. JWS reports personal fees outside the submitted work from Angelini, Eisai, and UCB Pharma.